On July 27, 2018 Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), reported that second quarter 2018 financial results will be released on Thursday, August 2, 2018 before the market opens (Press release, Cambrex, JUL 27, 2018, View Source [SID1234527929]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company will host a conference call to discuss the financial results.

Second Quarter 2018 Earnings Conference Call
When: Thursday, August 2, 2018 at 8:30 a.m. Eastern Time
Dial-in: 1-888-208-1711 for U.S.
+1-323-794-2575 for International
Passcode: 3913181
Dial-in Replay: 1-888-203-1112 for U.S.
+1-719-457-0820 for International
Passcode: 3913181
Available through Thursday, August 9, 2018
Webcast: www.cambrex.com